Clinical Trial Update: Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating irinotecan hydrochloride liposome injection (II) in combination with oxaliplatin and 5-FU/Leucovorin versus AG as first-line therapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Irinotecan hydrochloride liposome injection (II) (irinotecan liposome injection)
• Leucovorin (folinic acid)
• Nab-paclitaxel (paclitaxel protein-bound)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: First-line Treatment of Metastatic Pancreatic Cancer | Phase 3 | Status: RECRUITING